Skip to content

Intended useFor research use only. Not for human or veterinary use.

AOD-9604 5 mg – vial with GOLDKERN label, studio shot with product name and logo

Illustration: digital rendering with the original label, not a photograph – vial, closure and contents may differ.

Lyophilised powder

AOD-9604

hGH fragment 177–191 with N-terminal tyrosine

Modified fragment of human growth hormone (amino acids 177–191) with an additional N-terminal tyrosine and a disulfide bridge, supplied as lyophilised research material.

Choose a variant

Price

€46.00

Currently unavailableSKU GK-AOD9604-05

incl. VAT, plus shipping

Shipping to Germany from €5.90. Free shipping from €150.00.

Get notified when available: Sign in

Delivery to Germany in 1–2 business days

Compare

Lab data

Current batch:No batch published yetNo released batch

  • Purity

    No published result yet

    HPLC

  • Identity

    No published result yet

    LC-MS / mass spectrometry

  • Heavy metals

    No published result yet

    ICP-MS

  • Endotoxins

    No published result yet

    LAL test

View batches & COA

AOD-9604 is a synthetic peptide of 16 amino acids. It corresponds to the C-terminal segment 177–191 of human growth hormone (hGH), extended by a tyrosine at the N-terminus.

Structure

  • Sequence: YLRIVQCRSVEGSCGF
  • Intramolecular disulfide bridge between Cys7 and Cys14, corresponding to the Cys182–Cys189 bridge in hGH
  • Free N- and C-terminus

As supplied

GOLDKERN supplies AOD-9604 as a lyophilised powder in a sealed vial. Every delivery is assigned to a batch; analytical data and the COA are published per batch as soon as they are available. The material is intended for research use only.

Peptide sequence
YLRIVQCRSVEGSCGF
Notation
One-letter code
Molecular formula
C78H123N23O23S2
Molecular weight
1,815.1 g/mol
CAS number
221231-10-3
Form
Lyophilised powder
Amount
5 mg · 10 mg
Storage
−20 °C
Purity
No documented HPLC result yet
Batch number
No batch published yet
PropertyDetails
FormLyophilised powder
AppearanceWhite to off-white powder
ModificationsIntramolecular disulfide bridge (Cys7–Cys14)
Counter-ionStated per batch in the COA
Net peptide contentStated per batch in the COA
Purity (HPLC)Stated per batch in the COA
Identity (LC-MS)Stated per batch in the COA

The quantity shown for a variant is the nominal amount per vial. The figures in the COA of the delivered batch are binding.

Batch-specific values are stated exclusively in the certificate of analysis (COA) of the respective batch.

Every batch has its own test data. Choose a batch to see purity, laboratory, test date and status. Values only appear if they are recorded for exactly this batch.

No batch has been published for this product yet.

AOD-9604 is the subject of scientific publications that come predominantly from preclinical research – in-vitro studies and work in animal models. The main thematic focus is on lipid metabolism.

The Goldkern Lexicon puts the current state of research into context, with cited sources.

GOLDKERN makes no statements about efficacy or use. The material is intended exclusively for laboratory research – not for human or veterinary use.

Research areas

Terms and methods in the Goldkern Lexicon

Assignment to a research area describes the field in which the substance is the subject of scientific investigation. It is no statement about effect or suitability.

Handling

Storage
  • Store the lyophilisate at −20 °C, dry and protected from light, in the sealed original container.
  • Lyophilised peptides are sensitive to moisture: open containers only briefly and reseal them tightly straight away.
  • Divide prepared solutions into aliquots and avoid repeated freeze–thaw cycles.
  • Information on shelf life is given in the documentation of the respective batch.
Handling
  • Allow the sealed vial to reach room temperature before opening so that no condensation forms on the powder.
  • Wear personal protective equipment: lab coat, protective gloves and safety glasses.
  • Avoid generating dust, do not inhale the powder and avoid contact with skin and eyes.
  • For use by qualified personnel in suitable laboratory facilities only.
  • Dispose of residues and contaminated materials in accordance with local regulations.

Information on hazards and disposal is provided in the safety data sheet, where one is available for the product.

Reconstitution

The following points describe general laboratory practice for lyophilised peptides. They do not replace a validated standard operating procedure and deliberately contain no quantities or concentrations.

Preparation
  • Choose the solvent based on the solubility information in the batch documentation and the requirements of your experimental set-up.
  • Bring the sealed vial to room temperature; collect loose powder at the bottom by tapping the vial gently or by a brief centrifugation.
  • Work aseptically: use sterile materials and a suitable workspace such as a biosafety cabinet.
Dissolving
  • Let the solvent run slowly down the inside wall of the vial rather than adding it directly onto the powder.
  • Dissolve by gentle swirling – vigorous shaking causes foaming and can promote aggregation.
  • Before further use, check that the material has dissolved completely and that the solution is free of particles.
Documentation and storage
  • Label the container with the solvent, the date and the batch number.
  • Aliquot solutions and store them as specified in the batch documentation.
Note on AOD-9604

The disulfide bridge is sensitive to reducing agents. Reducing additives such as DTT or TCEP cleave it and should only be used where this is an intended part of the experiment.

Concentrations can be converted purely mathematically with the Goldkern Lab Calculator.

No documents have been released for this product yet.

Related research topics

Further reference materials from the same research areas.

  • MOTS-c

    Mitochondrially encoded peptide · 16 amino acids

    from €49.00

    40 mg · 3 variants

    Currently unavailableNo released batch

    Purity: test pending